138 related articles for article (PubMed ID: 20859850)
1. [Effects of the 12th amendment to the German drug code on investigator-initiated clinical trials].
Kehrel U
Gesundheitswesen; 2011 Oct; 73(10):696-701. PubMed ID: 20859850
[TBL] [Abstract][Full Text] [Related]
2. [Clinical trials with minors in Germany--effects of the 12th amendment to the German Drug Code on the numbers of applications to Institutional Review Boards (IRB)].
Kölch M; Märsch C; Fegert JM; Lippert HD
Gesundheitswesen; 2009 Mar; 71(3):127-33. PubMed ID: 19221985
[TBL] [Abstract][Full Text] [Related]
3. [The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials?].
Schwarz S; Frölich L; Striebel JP; Hennerici MG
Dtsch Med Wochenschr; 2007 Jan; 132(3):108-12. PubMed ID: 17219346
[No Abstract] [Full Text] [Related]
4. [The 12th amendment to the German Drug Law. Chances and obstacles for investigator-initiated clinical trials].
Dreier G; Marx C; Schmoor C; Maier-Lenz H
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):445-52. PubMed ID: 15830256
[TBL] [Abstract][Full Text] [Related]
5. [Consequences of the 12th AMG amendment on the conduct of non-commercial clinical trials].
Rossion I
Urologe A; 2005 Dec; 44(12):1444-8. PubMed ID: 16283155
[TBL] [Abstract][Full Text] [Related]
6. Academic investigator-initiated trials and the challenge of sponsor responsibility: the Cologne Sponsor Model.
Georgias C; Grunow A; Olderog M; May A; Paulus U
Clin Trials; 2012 Dec; 9(6):781-7. PubMed ID: 23104975
[TBL] [Abstract][Full Text] [Related]
7. [The effects of the 12th and 14th amendments to the AMG (Medical Preparations Act) on paediatric pharmaceutical research--a survey of the new regulations].
Kölch M; Lippert HD; Fegert JM
Z Kinder Jugendpsychiatr Psychother; 2006 Mar; 34(2):117-26. PubMed ID: 16610597
[TBL] [Abstract][Full Text] [Related]
8. [Non-commercial clinical trials--who will be the legal sponsor? Sponsorship of investigator-initiated clinical trials according to the German Drug Law].
Benninger-Döring G; Boos J
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Jul; 49(7):675-80. PubMed ID: 16763801
[TBL] [Abstract][Full Text] [Related]
9. [Clinical research with pharmaceutical agents in Germany: effects of the 12th amendment to the German Drug Law].
Götte D; Weihrauch TR
Internist (Berl); 2004 Jun; 45 Suppl 1():S48-54. PubMed ID: 15138642
[TBL] [Abstract][Full Text] [Related]
10. The clinician as investigator: participating in clinical trials in the practice setting.
Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
Circulation; 2004 Jun; 109(21):2672-9. PubMed ID: 15173050
[TBL] [Abstract][Full Text] [Related]
11. [Focus on academic multicenter trials: impact of the German drug law on hematological/oncological therapy optimization trials].
Ihrig K; Fath B; Fuchs M; Hallek M; Marschner N; Naumann R; Röllig C; Saussele S; Tesch H; Gökbuget N
Onkologie; 2013; 36 Suppl 2():23-8. PubMed ID: 23549033
[TBL] [Abstract][Full Text] [Related]
12. [How to establish GCP-units in Denmark?].
Krogsgaard K; Andreasen PB
Ugeskr Laeger; 2003 Apr; 165(16):1665-7. PubMed ID: 12756825
[TBL] [Abstract][Full Text] [Related]
13. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
Englev E; Petersen KP
Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
[TBL] [Abstract][Full Text] [Related]
14. Investigator responsibilities for clinical research studies: proper staffing can ensure an investigator is compliant.
Kee AN
J Med Pract Manage; 2011; 26(4):245-7. PubMed ID: 21506468
[TBL] [Abstract][Full Text] [Related]
15. [Survey of the simultaneous management of clinical and research burdens in German University orthopaedic and trauma departments].
Bernstein P; Stiehler M; Haasper C
Z Orthop Unfall; 2010 Mar; 148(2):155-62. PubMed ID: 20376757
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of innovations in clinical research: strengths and potentials for improvement of research in Germany].
Vollmar HC; Georgieff P; Bührlen B
Z Evid Fortbild Qual Gesundhwes; 2010; 104(10):738-43. PubMed ID: 21147437
[TBL] [Abstract][Full Text] [Related]
17. [Differences between clinical trials according to the German law on pharmaceuticals (Arzneimittelgesetz) and trials according to the German law on medical products (Medizinproduktegesetz)].
Krummenauer F
Ophthalmologe; 2003 Feb; 100(2):150-4. PubMed ID: 12589461
[TBL] [Abstract][Full Text] [Related]
18. Managing clinical grant costs.
Glass HE; Hollander K
Contemp Clin Trials; 2009 May; 30(3):221-6. PubMed ID: 19470309
[TBL] [Abstract][Full Text] [Related]
19. Inspection of clinical investigations by the German health authorities.
Schmidt M
Methods Find Exp Clin Pharmacol; 1993 May; 15(4):229-31. PubMed ID: 8361260
[TBL] [Abstract][Full Text] [Related]
20. Clinical trials: considerations for researchers and hospital administrators.
Uecke O; Reszka R; Linke J; Steul M; Posselt T
Health Care Manage Rev; 2008; 33(2):103-12. PubMed ID: 18360161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
